drugset / Trial / NCT05839236

COVID-19 Vaccination Detoxification in LDL-C

NCT05839236

Phase 1 Unknown 1 enrolled Yang I. Pachankis
NaSequentialOpen-labelTreatment

Summary

The study hypothesizes that SARS-CoV-2 vaccination poisoning hibernates in human host in Low Density Lipoprotein Cholesterol (LDL-C). The clinical trial is a follow-up from the intervention trial with NCT number NCT05711810. It tests the use of Atorvastatin Calcium Tablets for detoxification and prevention of blood acidification, and the use of the Chinese herb compounded Anti-Viral Granules for the detoxification in the endocrine system.

Timeline

Start
2023-05-01
Primary completion
2023-06-30
Completion
2023-07-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Anti-Viral Granules Traditional medicine (herbal / TCM) 12 g
Subject Atorvastatin Small molecule 20 mg